Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Elimination of hepatitis C news


From To
Tackling HIV and hepatitis C in Europe: towards minimum standards

Despite the huge disparities in care that were highlighted, last week's Standard of Care for HIV and Coinfections in Europe meeting in Bucharest featured discussions that could form

08 February 2019
Gus Cairns
England: Countdown to hep C eradication

NHS England’s target date to eliminate hepatitis C is now just six years away. DDN hears what progress has been made, and what’s left to achieve, at the LJWG on Substance Use and Hepatitis C annual conference.

05 February 2019
Drink & Drug News
UK court dismisses AbbVie's legal challenge against the NHS

The High Court has dismissed a legal challenge by US pharmaceutical firm AbbVie against the National Health Service (NHS) England's procurement deal for drugs to treat and cure hepatitis C. The decision means that the plan to eliminate the virus in England remains on track.

25 January 2019
The Lancet (free registration required)
NHS England’s plan to eliminate Hepatitis C decisively backed by High Court

NHS England’s plan to eliminate Hepatitis C in England by 2025 is on track after all aspects of a High Court challenge by pharmaceutical company AbbVie were dismissed. The NHS’s single largest medicines procurement, a deal worth almost £1 billion over five years, was launched in April last year but contract start dates had to be delayed by six months after legal action by AbbVie.

18 January 2019
NHS England
Egypt proposes plan to treat African Hepatitis C patients

Minister of Health Hala Zayed unveiled an Egyptian initiative to treat African people from Hepatitis C, starting with the Nile Basin countries who have an estimated 3.7 million hepatitis C patients, representing 30 percent of the total number of infected people in Africa.

16 January 2019
Australian experience shows high DAA uptake and rapid fall in rates of HCV viraemia among people who inject drugs

Providing hepatitis C virus (HCV) therapy with direct-acting antivirals (DAAs) to people who inject drugs can achieve rapid reductions in community prevalence of viraemia, according

28 November 2018
Michael Carter
Hepatitis C elimination in people living with HIV in the UK is feasible by 2021, British HIV Association says

Hepatitis C co-infection can be eliminated in people living with HIV in the United Kingdom by 2021, the British HIV Association (BHIVA) said today. “The UK can be

10 October 2018
Keith Alcorn
Hepatitis C in England: 2018 report

In this report, we summarise the impact of action plans in England to drive down mortality from HCV, reduce the number of new infections, and outline the actions required to make further progress.

08 May 2018
Public Health England
Routine clinical use of DAAs highly effective and safe in people with HIV/HCV in Europe

“Real life” data from across Europe shows that direct-acting antivirals (DAAs) cure hepatitis C in the vast majority of people with HIV and hepatitis C

19 April 2018
Michael Carter
Eliminating Hepatitis C in England

England will not fulfil its commitment to elimination of hepatitis C by 2030 unless the number of people diagnosed and initiated onto treatment is greatly increased.

23 March 2018
All-Party Parliamentary Group on Liver Health
← First123...4Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.